This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08725/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB08725/identifier/chemspider/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08725/identifier/pdb/

Statements

Subject Item
n2:DB08725
rdf:type
n3:Drug
n3:description
5-(7-(5-hydro-4-ethyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. This substance targets the protein genome polyprotein.
n3:group
experimental
owl:sameAs
n10:DB08725 n11:DB08725
dcterms:title
5-(7-(5-hydro-4-ethyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole
adms:identifier
n7:2340028 n8:DB08725 n12:W59
n3:IUPAC-Name
n4:271B4DC4-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4DCA-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4DC9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4DC6-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4DC7-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4DC8-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4DC2-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4DC0-363D-11E5-9242-09173F13E4C5 n4:271B4DC3-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4DC1-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4DD0-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4DD1-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4DCB-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4DCC-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4DCE-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4DCD-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4DCF-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4DD5-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4DD7-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4DD8-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4DD4-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4DD3-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4DD6-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4DC5-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4DD2-363D-11E5-9242-09173F13E4C5